litlas
Log inCreate account

Aaron R. Hansen

Active 2013–2025

148
Papers
19,264
Citations
57
h-index
139
i10-index

Citations

Citations per year for Aaron R. Hansen2007: 2 citations2010: 1 citations2013: 2 citations2014: 24 citations2015: 38 citations2016: 61 citations2017: 85 citations2018: 106 citations2019: 410 citations2020: 887 citations2021: 1,196 citations2022: 1,188 citations2023: 857 citations2024: 1,408 citations2025: 781 citations2026: 14 citations2008–2009: no citations, so these years are not shown2011–2012: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,592 citing papers, 22.6% of this breakdownChina: 1,506 citing papers, 13.1% of this breakdownItaly: 704 citing papers, 6.2% of this breakdownUnited Kingdom: 603 citing papers, 5.3% of this breakdownCanada: 543 citing papers, 4.7% of this breakdownGermany: 535 citing papers, 4.7% of this breakdownFrance: 495 citing papers, 4.3% of this breakdownJapan: 440 citing papers, 3.8% of this breakdownSpain: 399 citing papers, 3.5% of this breakdownAustralia: 302 citing papers, 2.6% of this breakdownNetherlands: 297 citing papers, 2.6% of this breakdownSwitzerland: 262 citing papers, 2.3% of this breakdown
0%22.6%Other 24.3%

Institutions

Fields

  • Medicine73.6%
  • Biochemistry, Genetics and Molecular Biology17.8%
  • Immunology and Microbiology4.2%
  • Engineering1.3%
  • Computer Science0.5%
  • Mathematics0.5%
  • Other2.1%

Topics

  • Cancer Immunotherapy and Biomarkers13.5%
  • Head and Neck Cancer Studies5%
  • Cancer Genomics and Diagnostics4.7%
  • Immunotherapy and Immune Responses3.1%
  • CAR-T cell therapy research2.7%
  • Lung Cancer Treatments and Mutations2.5%
  • Other68.5%

Coauthors

All papers

Open in search
  1. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

    Authors: Barbara Burtness, Kevin J. Harrington, Richard Greil, Denis Soulières, Makoto Tahara, Gilberto de Castro, Amanda Psyrri, Neus Basté, Prakash Neupane, Åse Bratland, Thorsten Fuereder, Brett Hughes, Ricard Mesı́a, Nuttapong Ngamphaiboon, Tamara Rordorf, Wan Zamaniah Wan Ishak, Ruey‐Long Hong, René González Mendoza, Ananya Roy, Yayan Zhang, Burak Gümüşçü, Jonathan D. Cheng, Fan Jin, Danny Rischin, Guillermo Lerzo, Marcelo Tatangelo, Mirta Varela, Juan José Zarbá, Michael Boyer, Hui Gan, Bo Gao, Brett Hughes, Girish Mallesara, Danny Rischin, Anne L. Taylor, Martin Burian, Thorsten Fuereder, Richard Greil, Carlos H. Barrios, Dalvaro Oliveira de Castro Junior, Gilberto de Castro, Fábio Franke, Gustavo Girotto, Iane Pinto Figueiredo Lima, Ulisses Ribaldo Nicolau, Gustavo Dix Junqueira Pinto, Lucas Vieira dos Santos, Ana-Paula Victorino, Neil Chua, Félix Couture, Richard Gregg, Aaron R. Hansen, John Hilton, Joy McCarthy, Denis Soulières, Rodrigo Ascuí, Pablo Gonzalez, Luis J. Villanueva-Rivera, Marco Torregroza, Ángela R. Zambrano, Petra Holečková, Zdeněk Král, Bohuslav Melichar, Prausova Jana, Milan Vošmik, Maria Andersen, Niels Gyldenkerne, Hannes Jürgens, Kadri Putnik, Petri Reinikainen, Viktor Gruenwald, Simon Laban, Gerasimos Aravantinos, Ioannis Boukovinas, Vassilis Georgoulias, Amanda Psyrri, D.L.W. Kwong, Yousuf Al-Farhat, Tibor Csőszi, József Erfán, Geza Horvai, László Landherr, Éva Remenár, Ágnes Ruzsa, Judit Szota, Salem Billan, Iris Gluck, Orit Gutfeld, Aron Popovtzer, Marco Benasso, Simona Bui, Vittorio Ferrari, Lisa Licitra, Franco Nolè, Takashi Fujii, Yasushi Fujimoto, Nobuhiro Hanai, Hiroki Hara, Koji Matsumoto, Kenji Mitsugi and 119 more - The Lancet 2019 cited by 3,211

  2. Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

    Authors: Aurélien Marabelle, Dung T. Le, Paolo A. Ascierto, Anna Maria Di Giacomo, Ana De Jesus‐Acosta, Jean-Pierre Delord, Ravit Geva, Maya Gottfried, Nicolas Penel, Aaron R. Hansen, Sarina A. Piha‐Paul, Toshihiko Doi, Bo Gao, Hyun Cheol Chung, José A. López-Martín, Yung-Jue Bang, Ronnie Shapira Frommer, Manisha H. Shah, Razi Ghori, Andrew K. Joe, Scott K. Pruitt, Luis A. Díaz - Journal of Clinical Oncology 2019 cited by 2,963

  3. Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review

    Authors: Leila Khoja, Daphne Day, Tom Wei‐Wu Chen, L.L. Siu, Aaron R. Hansen - Annals of Oncology 2017 cited by 921

  4. Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab

    Authors: Scott V. Bratman, S.Y. Cindy Yang, Marco Iafolla, Zhihui Liu, Aaron R. Hansen, Philippe L. Bédard, Stéphanie Lheureux, Anna Spreafico, Albiruni Abdul Razak, Svetlana Shchegrova, Maggie C. Louie, Paul R. Billings, Bernhard Zimmermann, Himanshu Sethi, Alexey Aleshin, Dax Torti, Kayla Marsh, Jenna Eagles, Iulia Cirlan, Youstina Hanna, Derek Clouthier, Scott Lien, Pamela S. Ohashi, Wei Xu, Lillian L. Siu, Trevor J. Pugh - Nature Cancer 2020 cited by 480

  5. Pembrolizumab in Patients With Microsatellite Instability–High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study

    Authors: David M. O’Malley, Giovanni M. Bariani, Philippe A. Cassier, Aurélien Marabelle, Aaron R. Hansen, A. De Jesus Acosta, Wilson H. Miller, Tamar Safra, Antoîne Italiano, Linda Mileshkin, Lei Xu, Fan Jin, Kevin Norwood, Michele Maio - Journal of Clinical Oncology 2022 cited by 498

  6. Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE‐158 and KEYNOTE‐028 studies

    Authors: Sarina A. Piha‐Paul, Do‐Youn Oh, Makoto Ueno, David Malka, Hyun Cheol Chung, Adnan Nagrial, Robin Kate Kelley, Willeke Ros, Antoîne Italiano, Kazuhiko Nakagawa, Hope S. Rugo, Filippo de Braud, Andréa Varga, Aaron R. Hansen, Hui Wang, Suba Krishnan, Kevin Norwood, Toshihiko Doi - International Journal of Cancer 2020 cited by 498

  7. Tumour heterogeneity in the clinic

    Authors: Philippe L. Bédard, Aaron R. Hansen, Mark J. Ratain, Lillian L. Siu - Nature 2013 cited by 1,230

  8. Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1–Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study

    Authors: Chiun Hsu, Se‐Hoon Lee, Samuel Ejadi, Caroline Even, Roger B. Cohen, Christophe Le Tourneau, Janice M. Mehnert, Alain P. Algazi, Emilie M.J. van Brummelen, Sanatan Saraf, Pradeep Thanigaimani, Jonathan D. Cheng, Aaron R. Hansen - Journal of Clinical Oncology 2017 cited by 471

  9. Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies

    Authors: John Hilton, Karen A. Gelmon, Philippe L. Bédard, Dongsheng Tu, Hong Xu, Anna V. Tinker, Rachel Goodwin, Scott A. Laurie, Derek J. Jonker, Aaron R. Hansen, Zachary Veitch, Daniel J. Renouf, Linda Hagerman, Hongbo Lui, Bingshu E. Chen, Deb Kellar, Irene Li, Sung‐Eun Lee, Takako Kono, Brian Yu Chieh Cheng, Damian Yap, Daniel Lai, Sean Beatty, John Soong, Kathleen I. Pritchard, Isabel Soria‐Bretones, Eric X. Chen, Harriet Feilotter, Moira Rushton, Lesley Seymour, Samuel Aparício, David W. Cescon - Nature Communications 2022 cited by 145

  10. Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival

    Authors: Shaan Dudani, Guillermo de Velasco, J. Connor Wells, Chun Loo Gan, Frede Donskov, Camillo Porta, Anna Paola Fraccon, Felice Pasini, Jae‐Lyun Lee, Aaron R. Hansen, Georg A. Bjarnason, Benoit Beuselinck, Sumanta K. Pal, Takeshi Yuasa, Nils Kroeger, Ravindran Kanesvaran, M. Neil Reaume, Christina Canil, Toni K. Choueiri, Daniel Y.C. Heng - JAMA Network Open 2021 cited by 299

  11. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group

    Authors: Benjamin Lacas, Alexandra Carmel, C. Landais, Stuart J. Wong, Lisa Licitra, Jeffrey Tobias, Barbara Burtness, Maria Grazia Ghi, Ezra E.W. Cohen, Cai Grau, Gregory T. Wolf, Ricardo Hitt, Renzo Corvò, Volker Budach, Shaleen Kumar, Sarbani Ghosh Laskar, Jean‐Jacques Mazeron, Lai‐ping Zhong, W. Dobrowsky, Pirus Ghadjar, C. Fallai, Branko Zakotnik, Atul Sharma, René‐Jean Bensadoun, Maria Grazia Ruo Redda, S. Racadot, George Fountzilas, David M. Brizel, P Rovea, Athanassios Argiris, Zoltán Takácsi Nagy, Ju‐Whei Lee, Catherine Fortpied, Jonathan Harris, Jean Bourhis, Anne Aupérin, Pierre Blanchard, Jean‐Pierre Pignon, David J. Adelstein, M. Alfonsi, Y. Belkacemi, Voichita Bar‐Ad, J. Bernier, Åse Bratland, G. Calais, Brittany Campbell, Jimmy J. Caudell, Sylvie Chabaud, Emmanuel Chamorey, Devendra Chaukar, Kwang Nam Choi, Olivier Choussy, Laurence Collette, Judith Cruz, Carla Dani, Etienne Dauzier, Arlene A. Forastiere, P. Garaud, V. Grégoire, A. Hackshaw, E. Haddad, Bruce G. Haffty, Aaron R. Hansen, Stefanie Hayoz, Jean-Claude Horiot, Branislav Jeremić, Theodore Karrison, Johannes A. Langendijk, M. Lapeyre, Éric Lartigau, Traci Leong, Quynh‐Thu Le, Patricia Lee, Freddi Lewin, Aihua Lin, Alberto Lopes, Samir Mehta, James Moon, Elizabeth Moyal, Bob‐Valéry Occéan, P. Olmi, Roberto Orecchia, Brian O’Sullivan, Jens Overgaard, Claire Petit, Harvey Quon, Giuseppe Sanguineti, Tuvana Satar, John Simes, Christian Simon, Clément Sire, S. Staar, C. Stromberger, P. Strojan, Stéphane Temam, David Thomson, A. Timochenko, Valter Torri, Vassilikì Tseroni, Jan B. Vermorken and 5 more - Radiotherapy and Oncology 2021 cited by 376

  12. Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study

    Authors: Aaron R. Hansen, Christophe Massard, Patrick A. Ott, Naomi B. Haas, Juanita Lopez, Samuel Ejadi, John M. Wallmark, Bhumsuk Keam, Jean‐Pierre Delord, Rahul Aggarwal, M. Gould, Peng Yang, Stephen J. O’Keefe, Sarina A. Piha‐Paul - Annals of Oncology 2018 cited by 367

  13. First-in-class Microbial Ecosystem Therapeutic 4 (MET4) in combination with immune checkpoint inhibitors in patients with advanced solid tumors (MET4-IO trial)

    Authors: Anna Spreafico, Alya Heirali, Daniel Vilarim Araújo, Tira J. Tan, Marc Oliva, Pierre H. H. Schneeberger, B. Chen, Michael K. Wong, Lee-Anne Stayner, Aaron R. Hansen, Samuel D. Saibil, B.X. Wang, Kristen C. Cochrane, Keith Sherriff, Emma Allen‐Vercoe, Wei Xu, L.L. Siu, Bryan Coburn - Annals of Oncology 2023 cited by 98

  14. Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

    Authors: Kevin J. Harrington, Robert L. Ferris, Maura L. Gillison, Makoto Tahara, A. Argiris, Jérôme Fayette, Michael Schenker, Åse Bratland, John Walker, Peter Grell, Caroline Even, Christine H. Chung, Rebecca Redman, Alexandre Coutté, Sébastien Salas, Clíona Grant, Sérgio de Azevedo, Denis Soulières, Aaron R. Hansen, Wei Li, Tariq Aziz Khan, Karen Miller-Moslin, Mustimbo Roberts, Robert I. Haddad - JAMA Oncology 2023 cited by 72

  15. Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors

    Authors: María Vieito, Víctor Moreno, Anna Spreafico, Irene Braña, Judy S. Wang, Meir Preis, Tatiana Hernández, Sofia Genta, Aaron R. Hansen, Bernard Doger, Vladimir Galvao, Laurie Lenox, Regina J. Brown, Anna Kalota, Jaydeep Mehta, Friederike Pastore, Bharvin Patel, Pankaj Mistry, Junchen Gu, Josh Lauring, Manish R. Patel - Clinical Cancer Research 2023 cited by 77

  16. CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial

    Authors: Andrew J. Armstrong, Ravit Geva, Hyun Cheol Chung, Charlotte Lemech, Wilson H. Miller, Aaron R. Hansen, Jong Seok Lee, Frank Tsai, Benjamin Solomon, Tae Min Kim, Christian Rolfo, Vincent L. Giranda, Yixin Ren, Fang Liu, Bhargava Kandala, Tomoko Freshwater, Judy S. Wang - Investigational New Drugs 2024 cited by 62

  17. Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium

    Authors: Silke Gillessen, Nicolas Sauvé, Laurence Collette, Gedske Daugaard, Ronald de Wit, Costantine Albany, A. Tryakin, Karim Fizazi, Olof Ståhl, Jourik A. Gietema, Ugo De Giorgi, Fay Cafferty, Aaron R. Hansen, Torgrim Tandstad, Robert Huddart, Andrea Necchi, Christopher J. Sweeney, Xavier García del Muro, Daniel Yick Chin Heng, Anja Lorch, Michal Chovanec, Eric Winquist, Peter Grimison, Darren R. Feldman, Angelika Terbuch, Marcus Hentrich, Carsten Bokemeyer, Helene F. S. Negaard, Christian D. Fankhauser, Jonathan Shamash, David J. Vaughn, Cora N. Sternberg, Axel Heidenreich, J. Beyer - Journal of Clinical Oncology 2021 cited by 238

  18. Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity

    Authors: S.Y. Cindy Yang, Scott Lien, Ben X. Wang, Derek Clouthier, Youstina Hanna, Iulia Cirlan, Kelsey Zhu, Jeffrey P. Bruce, Samah El Ghamrasni, Marco Iafolla, Marc Oliva, Aaron R. Hansen, Anna Spreafico, Philippe L. Bédard, Stéphanie Lheureux, Albiruni Abdul Razak, Vanessa Speers, Hal K. Berman, Alexey Aleshin, Benjamin Haibe‐Kains, David G. Brooks, Tracy L. McGaha, Marcus O. Butler, Scott V. Bratman, Pamela S. Ohashi, Lillian L. Siu, Trevor J. Pugh - Nature Communications 2021 cited by 128

  19. Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2

    Authors: Linh T. Nguyen, Samuel D. Saibil, Valentin Sotov, Michael X. Le, Leila Khoja, Danny Ghazarian, Luisa Bonilla, Habeeb Majeed, David Hogg, Anthony M. Joshua, Michael Crump, Norman Franke, Anna Spreafico, Aaron R. Hansen, Ayman Al‐Habeeb, Wey L. Leong, Alexandra Easson, Michael Reedijk, David P. Goldstein, David R. McCready, Kazuhiro Yasufuku, Thomas K. Waddell, Marcelo Cypel, Andrew Pierre, Bianzheng Zhang, Sarah Boross-Harmer, Jane Cipollone, Megan Nelles, Elizabeth Scheid, Michael Fyrsta, Charlotte S. Lo, Jessica Nie, Jennifer Yam, Pei Hua Yen, Diana Gray, Vinicius N. Motta, Alisha R. Elford, Stephanie DeLuca, Lisa Wang, Stephanie Effendi, Ragitha Ellenchery, Naoto Hirano, Pamela S. Ohashi, Marcus O. Butler - Cancer Immunology Immunotherapy 2019 cited by 141

  20. First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1)

    Authors: Sophie Postel‐Vinay, Vincent K. Lam, Willeke Ros, Todd M. Bauer, Aaron R. Hansen, Daniel C. Cho, F. Stephen Hodi, Jan H.M. Schellens, Jennifer K. Litton, Sandrine Aspeslagh, Karen A. Autio, Frans L. Opdam, Meredith McKean, Neeta Somaiah, Stéphane Champiat, Mehmet Altan, Anna Spreafico, Osama E. Rahma, Elaine Paul, Christoph M. Ahlers, Helen Zhou, Herbert Struemper, Shelby Gorman, Maura Watmuff, Kaitlin M Yablonski, Niranjan Yanamandra, Michael Chisamore, Emmett V. Schmidt, Axel Hoos, Aurélien Marabelle, Jeffrey S. Weber, John V. Heymach - Journal for ImmunoTherapy of Cancer 2023 cited by 63

  21. Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer

    Authors: Emerson A. Lim, Michael T. Schweizer, Kim N., Rahul Aggarwal, Neeraj Agarwal, James L. Gulley, Edward F. Attiyeh, James Greger, Shujian Wu, Pharavee Jaiprasart, John T. Loffredo, Nibedita Bandyopadhyay, Hong Xie, Aaron R. Hansen - Clinical Genitourinary Cancer 2023 cited by 58

  22. A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial

    Authors: Grainne M. O’Kane, Shereen Ezzat, Anthony M. Joshua, Isabelle Bourdeau, Raya Leibowitz‐Amit, Harold J. Olney, Monika K. Krzyzanowska, Dean Reuther, Soo Chin, Lisa Wang, Kelly Brooks, Aaron R. Hansen, L. Sylvia, Jennifer J. Knox - British Journal of Cancer 2019 cited by 122

  23. Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy

    Authors: Giselle M. Boukhaled, Ramy Gadalla, Heidi Elsaesser, Diala Abd-Rabbo, Rene Quevedo, S.Y. Cindy Yang, Mengdi Guo, Ben X. Wang, Babak Noamani, Diana Gray, Sally C. M. Lau, Kirsty Taylor, Kyaw Aung, Anna Spreafico, Aaron R. Hansen, Samuel D. Saibil, Naoto Hirano, Cynthia J. Guidos, Trevor J. Pugh, Tracy L. McGaha, Pamela S. Ohashi, Adrian G. Sacher, Marcus O. Butler, David G. Brooks - Nature Immunology 2022 cited by 51

  24. The microbiome and cancer for clinicians

    Authors: Sarah Picardo, Bryan Coburn, Aaron R. Hansen - Critical Reviews in Oncology/Hematology 2019 cited by 152